TY - JOUR
T1 - Effect of cardiopulmonary bypass on fentanyl distribution and elimination
AU - Koska, Adolph J.
AU - Romagnoli, Alexander
AU - Kramer, William G.
PY - 1981/1
Y1 - 1981/1
N2 - Fentanyl kinetics was studied in two groups of six patients, one group undergoing surgery with and one without cardiopulmonary bypass; the latter served as the controls. Plasma fentanyl concentrations declined biexponentially in the control patients with an average half‐life (t½β) of 3.3 ± 1.1 hr, total plasma clearance of 11.2 ±3.4 ml/min/kg, and volume of distribution (Vdβ) of 3.2 ± 1.5 l/kg. The plasma concentration/time curves were severely disrupted during cardiopulmonary bypass but appeared to regain a log‐linear decay once bypass was complete. This elimination phase had a t½ of 5.2 ± 2.7 hr, longer than that in the control patients. Since fentanyl is eliminated primarily by hepatic metabolism, decreased liver plasma flow observed during and after bypass, as evidenced by a 30% decrease in indocyanine green clearance, may contribute to the extended t½. The prolonged t½ has clinical importance because of potentially prolonged effects and their relation to other drugs and the clinical management of the patient. Clinical Pharmacology and Therapeutics (1981) 29, 100–105; doi:
AB - Fentanyl kinetics was studied in two groups of six patients, one group undergoing surgery with and one without cardiopulmonary bypass; the latter served as the controls. Plasma fentanyl concentrations declined biexponentially in the control patients with an average half‐life (t½β) of 3.3 ± 1.1 hr, total plasma clearance of 11.2 ±3.4 ml/min/kg, and volume of distribution (Vdβ) of 3.2 ± 1.5 l/kg. The plasma concentration/time curves were severely disrupted during cardiopulmonary bypass but appeared to regain a log‐linear decay once bypass was complete. This elimination phase had a t½ of 5.2 ± 2.7 hr, longer than that in the control patients. Since fentanyl is eliminated primarily by hepatic metabolism, decreased liver plasma flow observed during and after bypass, as evidenced by a 30% decrease in indocyanine green clearance, may contribute to the extended t½. The prolonged t½ has clinical importance because of potentially prolonged effects and their relation to other drugs and the clinical management of the patient. Clinical Pharmacology and Therapeutics (1981) 29, 100–105; doi:
UR - http://www.scopus.com/inward/record.url?scp=0019474698&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019474698&partnerID=8YFLogxK
U2 - 10.1038/clpt.1981.16
DO - 10.1038/clpt.1981.16
M3 - Article
C2 - 6970110
AN - SCOPUS:0019474698
SN - 0009-9236
VL - 29
SP - 100
EP - 105
JO - Clinical Pharmacology & Therapeutics
JF - Clinical Pharmacology & Therapeutics
IS - 1
ER -